MicroRNA-98 Attenuates Cell Migration and Invasion in Glioma by Directly Targeting Pre-B Cell Leukemia Homeobox 3

被引:27
作者
Xu, Xiupeng [1 ]
Bao, Zhongyuan [1 ]
Liu, Yinlong [1 ]
Ji, Jing [1 ]
Liu, Ning [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Glioma; miR-98; PBX3; Invasion; Migration; PROSTATE-CANCER; COLORECTAL-CANCER; DOWN-REGULATION; BREAST-CANCER; FEEDBACK LOOP; LUNG-CANCER; PROLIFERATION; METASTASIS; PBX3; GLIOBLASTOMA;
D O I
10.1007/s10571-017-0466-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults. The extraordinary invasion of human GBM into adjacent normal brain tissues contributes to treatment failure. However, the mechanisms that control this process remain poorly understood. Increasing evidence has demonstrated that microRNAs are strongly implicated in the migration and invasion of GBM. In this study, we found that microRNA-98 (miR-98) was markedly downregulated in human glioma tissues and cell lines. Functional experiments indicated that restored expression of miR-98 attenuated glioma cell invasion and migration, whereas depletion of miR-98 promoted glioma cell invasion and migration. Subsequent investigation showed that pre-B-cell leukemia homeobox 3 (PBX3), an important transcription factor that controls tumor invasion, was a direct and functional target of miR-98 in GBM cells. Consistently, an orthotopic mouse model also demonstrated the suppressive effects of miR-98 overexpression on tumor invasion and PBX3 expression. Silencing of PBX3 using small interfering RNA inhibited the migratory and invasive capacities of glioma cells, whereas reintroduction of PBX3 into glioma cells reversed the anti-invasive function of miR-98. Furthermore, depletion of PBX3 phenocopied the effects of miR-98 overexpression in vivo. Finally, quantitative real-time polymerase chain reaction results showed that miR-98 was negatively correlated with PBX3 expression in 24 glioma tissues. Thus, we propose that PBX3 modulation by miR-98 has an important role in regulating GBM invasion and may serve as therapeutic target for GBM.
引用
收藏
页码:1359 / 1371
页数:13
相关论文
共 46 条
  • [1] Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98
    Alajez, N. M.
    Shi, W.
    Hui, A. B. Y.
    Bruce, J.
    Lenarduzzi, M.
    Ito, E.
    Yue, S.
    O'Sullivan, B.
    Liu, F-F
    [J]. CELL DEATH & DISEASE, 2010, 1 : e85 - e85
  • [2] Auffinger B, 2013, CURR MOL MED, V13, P535
  • [3] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [4] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [5] Chang CP, 1996, MOL CELL BIOL, V16, P1734
  • [6] IKKβ Enforces a LIN28B/TCF7L2 Positive Feedback Loop That Promotes Cancer Cell Stemness and Metastasis
    Chen, Chong
    Cao, Fengqi
    Bai, Lipeng
    Liu, Yan
    Xie, Junling
    Wang, Wei
    Si, Qin
    Yang, Jian
    Chang, Antao
    Liu, Dong
    Liu, Dachuan
    Chuang, Tsung-Hsien
    Xiang, Rong
    Luo, Yunping
    [J]. CANCER RESEARCH, 2015, 75 (08) : 1725 - 1735
  • [7] miR-429 inhibits glioma invasion through BMK1 suppression
    Chen, Weiyi
    Zhang, Baogang
    Guo, Wenjun
    Gao, Linlin
    Shi, Lihong
    Li, Hongli
    Lu, Shijun
    Liu, Yuqing
    Li, Xiaolong
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 125 (01) : 43 - 54
  • [8] Overexpression of RKIP Inhibits Cell Invasion in Glioma Cell Lines through Upregulation of miR-98
    Chen, Zigui
    Cheng, Quan
    Ma, Zhiming
    Xi, Haipeng
    Peng, Renjun
    Jiang, Bing
    [J]. BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [9] CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
    Dolecek, Therese A.
    Propp, Jennifer M.
    Stroup, Nancy E.
    Kruchko, Carol
    [J]. NEURO-ONCOLOGY, 2012, 14 : v1 - v49
  • [10] Du Y, 2015, INT J CLIN EXP PATHO, V8, P12252